In yesterday’s Wall Street session, ATAI Life Sciences N.V (NASDAQ:ATAI) shares traded at $2.45, up 8.89% from the previous session.
ATAI stock price is now 60.17% away from the 50-day moving average and 69.11% away from the 200-day moving average. The market capitalization of the company currently stands at $411.12M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $15 to $10, H.C. Wainwright maintained Buy rating for ATAI Life Sciences N.V (NASDAQ: ATAI). On April 03, 2024, Maxim Group Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock keeping its target price maintained at $6, while ‘Loop Capital’ rates the stock as ‘Buy’
In other news, ATAI Life Sciences N.V., 10% Owner sold 2,660,000 shares of the company’s stock on Sep 26 ’24. The stock was sold for $16,093,000 at an average price of $6.05. Upon completion of the transaction, the 10% Owner now directly owns 6,905,774 shares in the company, valued at $16.92 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 16 ’24, Brand Florian sold 151,303 shares of the business’s stock. A total of $290,502 was realized by selling the stock at an average price of $1.92. This leaves the insider owning 328,697 shares of the company worth $0.81 million. A total of 30.26% of the company’s stock is owned by insiders.
During the past 12 months, ATAI Life Sciences N.V has had a low of $1.03 and a high of $2.85. As of last week, the company has a debt-to-equity ratio of 0.16, a current ratio of 5.81, and a quick ratio of 5.81. The fifty day moving average price for ATAI is $1.5124 and a two-hundred day moving average price translates $1.4461 for the stock.
The latest earnings results from ATAI Life Sciences N.V (NASDAQ: ATAI) was released for 2024-09-30. The net profit margin was -38852.87% and return on equity was -62.43% for ATAI. The company reported revenue of $40000.0 for the quarter, compared to $87000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -54.02 percent. For the current quarter, analysts expect ATAI to generate $250k in revenue.
